EORTC

Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO) were trading lower by nearly 4 percent Tuesday morning after the company issued a clinical strategy update. Inovio Pharmaceuticals stated that it will take its INO-3112 HPV immunotherapy into human studies in combination with selected immunotherapy...